Evidence map›Paper›PMID 36038903›Full record

ArticleAntimicrobial resistance and infection control2022

What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres.

Agnese Comelli, Camilla Genovese, Andrea Lombardi, Chiara Bobbio, Luigia Scudeller, Umberto Restelli, Antonio Muscatello, Spinello Antinori, Paolo Bonfanti, Salvatore Casari and 17 more

Abstract readLetter
In one paragraph

Article in Antimicrobial resistance and infection control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. A large multicenterJournal of infection prevention · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Confronting antimicrobial resistance together.American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Agnese ComelliInfectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy. agnese.comelli@gmail.com.
Camilla GenoveseUniversity of Milan, Milan, Italy.
Andrea LombardiInfectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy.
Chiara BobbioInfectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy.
Luigia ScudellerResearch and Innovation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Umberto RestelliLIUC Cattaneo University, Castellanza, VA, Italy.
Antonio MuscatelloInfectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy.
Spinello AntinoriDepartment of Biomedical and Clinical Sciences DIBIC, Luigi Sacco, Università Degli Studi di Milano, Milan, Italy.
Paolo BonfantiInfectious Diseases Unit, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
Salvatore CasariUnit of Infectious Diseases, Carlo Poma Hospital, ASST Mantova, Mantua, Italy.
Antonella CastagnaInfectious Diseases Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Francesco CastelliUniversity Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili, Brescia, Italy.
Antonella d'Arminio MonforteDepartment of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo E Carlo, University of Milan, Milan, Italy.
Fabio FranzettiInfectious Diseases Unit, ASST Valle Olona, Busto Arsizio Hospital, Busto Arsizio, Italy.
Paolo GrossiInfectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria and ASST-Sette Laghi, Varese, Italy.
Matteo LupiDivision of Infectious Diseases, ASST Cremona, Cremona, Italy.
Paola MorelliInfectious Disease Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Stefania PiconiInfectious Diseases Unit, Alessandro Manzoni Hospital, ASST Lecco, Lecco, Italy.
Massimo PuotiInfectious Diseases, Hospital Niguarda, Milan, Italy.
Luigi PusterlaDivision of Infectious Diseases, ASST Lariana, Como, Italy.
Angelo RegazzettiUOC Di Malattie Infettive E Tropicali - Ospedale Delmati di Sant'Angelo Lodigiano, ASST Di Lodi, Lodi, Italy.
Marco RizziInfectious Diseases Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Stefano RusconiInfectious Diseases Unit, Ospedale Civile di Legnano, ASST Ovest Milanese, Legnano, Italy.
Valentina ZuccaroDivision of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Andrea GoriInfectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy.
Alessandra BanderaInfectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy.
ASP Lomb Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Discontinuation of antimicrobial stewardship programs (ASPs) and increased antibiotic use were described during SARS-CoV-2 pandemic. In order to measure COVID-19 impact on ASPs in a setting of high multidrug resistance organisms (MDRO) prevalence, a qualitative survey was designed. In July 2021, eighteen ID Units were asked to answer a questionnaire about their hospital characteristics, ASPs implementation status before the pandemic and impact of SARS-CoV-2 pandemic on ASPs after the 1st and 2nd pandemic waves in Italy. Nine ID centres (50%) reported a reduction of ASPs and in 7 cases (38.9%) these were suspended. After the early pandemic waves, the proportion of centres that restarted their ASPs was higher among the ID centres where antimicrobial stewardship was formally identified as a priority objective (9/11, 82%, vs 2/7, 28%). SARS-CoV-2 pandemic had a severe impact in ASPs in a region highly affected by COVID-19 and antimicrobial resistance but weaknesses related to the pre-existent ASPs might have played a role.

Indexed as

Antimicrobial StewardshipCommunicable DiseasesCOVID-19HumansPandemicsSARS-CoV-2Surveys and QuestionnairesAntimicrobial stewardshipAntimicrobials useCOVID-19Multidrug resistant organismsSARS-CoV-2

Identifiers

PMID36038903
PMCPMC9421115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.